Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study for Analysis of the Optimal Application Dose of Superficial Hyperthermia

NCT00766233 is registered in ClinicalTrials.gov with Universitätsmedizin Mannheim as lead sponsor.

NCT NCT00766233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00766233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study for Analysis of the Optimal Application Dose of Superficial Hyperthermia
Lead sponsor
Universitätsmedizin Mannheim
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
February 29, 2016
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tumors